France
Gnosis by Lesaffre is a biotechnology startup specializing in biotransformation processes like fermentation to cultivate active ingredients, probiotics, nutritional and functional yeasts that promote human health and well-being. The company collaborates with pharmaceutical and nutraceutical brands to develop innovative products harnessing the power of microorganisms. With a focus on wellness, immune health, digestion, mobility, reproduction, and cognitive health, Gnosis applies rigorous research, quality standards, and clinical validation to ensure effective solutions.
Key products include Quatrefolic®, a bioactive form of folate, LifeinU™ BSCU1, a patented immune system support strain, S.boulardii, a probiotic yeast for digestive disorders, Adonat®, which supports brain functioning and body health, and VitaMK7®, known for regulating calcium levels. Gnosis' commitment to sustainable production aligns with its parent company, Lesaffre's mission to "work together to better nourish and protect the planet."
Founded in 1989, Gnosis operates in the biotechnology, life sciences, pharmaceutical, and clean energy sectors. While specific headquarters and recent investments are undisclosed, the company's focus on leveraging biotechnology for human health and sustainable practices positions it as an attractive opportunity for potential investors in the biotech and pharmaceutical industries.
